Alpha Tau Medical Ltd. (DRTS) Income Statement
DRTS 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsDRTS revenue and net income
DRTS growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
DRTS quarterly EPS vs estimates
Alpha Tau Medical beat the analyst EPS estimate in 3 of the last 8 quarters. Next report: November 19, 2026 (estimate $-0.14).
DRTS income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $1.2M | $1.1M | $1.1M | $979,000 | $776,000 | $86,000 | — |
| Gross profit | −$1.2M | −$1.1M | −$1.1M | −$979,000 | −$776,000 | −$86,000 | — |
| Research & development | $30.8M | $27.0M | $26.4M | $20.9M | $11.4M | $7.5M | $6.6M |
| Sales, general & admin | $10.2M | $9.0M | $9.3M | $11.2M | $2.3M | $1.7M | $1.4M |
| Total operating expenses | $41.1M | $36.0M | $35.7M | $32.1M | $13.8M | $9.2M | $8.0M |
| Operating income | −$42.3M | −$36.0M | −$35.7M | −$32.1M | −$13.8M | −$9.2M | −$8.0M |
| Interest income | $3.8M | $4.3M | $4.8M | $1.8M | $211,000 | $613,000 | $776,000 |
| Interest expense | $419,000 | $303,000 | $75,000 | $1.8M | $12.7M | $217,000 | $1.3M |
| Income before taxes | −$42.5M | −$31.7M | −$29.1M | −$33.7M | −$27.3M | −$8.7M | −$8.3M |
| Income taxes | $121,000 | $6,000 | $16,000 | $20,000 | $7,000 | $158,000 | $146,000 |
| Net income | −$42.6M | −$31.8M | −$29.2M | −$33.8M | −$27.3M | −$8.9M | −$8.5M |
| EBITDA | −$41.1M | −$30.3M | −$28.0M | −$31.2M | −$13.0M | −$9.2M | −$7.9M |
| EPS (diluted) | −$0.53 | −$0.45 | −$0.60 | −$0.66 | −$0.12 | −$0.13 | −$0.13 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — | — | — | $1.1M | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | −$1.1M | — |
| Research & development | $9.9M | $11.0M | $9.6M | $8.3M | $7.0M | $7.2M | $7.5M | $6.2M | $6.9M | $6.4M | $7.5M | $6.7M |
| Sales, general & admin | $3.9M | $2.3M | $3.0M | $2.4M | $2.6M | $2.1M | $2.7M | $2.1M | $2.2M | $2.0M | $2.0M | $2.3M |
| Total operating expenses | $13.8M | $13.3M | $12.6M | $10.7M | $9.6M | $9.3M | $10.3M | $8.3M | $9.1M | $8.4M | $8.9M | $8.9M |
| Operating income | −$13.8M | −$13.3M | −$12.6M | −$10.7M | −$9.6M | −$9.3M | −$10.3M | −$8.3M | −$9.1M | −$8.4M | −$9.9M | −$8.9M |
| Interest expense | $31.8M | $9.6M | — | $2.3M | — | — | — | — | — | — | — | $2.0M |
| Income before taxes | −$45.6M | −$22.9M | −$12.2M | −$11.7M | −$10.0M | −$8.6M | −$9.5M | −$6.9M | −$7.4M | −$8.0M | −$7.4M | −$5.0M |
| Income taxes | $229,000 | −$11,000 | −$35,000 | −$8,000 | $65,000 | $99,000 | $2,000 | — | $3,000 | $1,000 | $8,000 | −$39,000 |
| Net income | −$45.8M | −$22.9M | −$12.1M | −$11.7M | −$10.1M | −$8.7M | −$9.5M | −$6.9M | −$7.4M | −$8.0M | −$7.4M | −$4.9M |
| EBITDA | −$13.8M | −$13.3M | −$11.2M | −$10.7M | −$9.2M | −$9.3M | −$5.4M | −$8.0M | −$8.8M | −$8.2M | −$8.9M | −$8.9M |
| EPS (diluted) | −$0.50 | −$0.26 | −$0.14 | −$0.14 | −$0.13 | −$0.12 | −$0.13 | −$0.10 | −$0.11 | −$0.11 | −$0.11 | −$0.25 |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in DRTS's financial statements (latest annual report filed March 9, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
DRTS financial results
Alpha Tau Medical reported no revenue in fiscal year 2025 (ended December 31, 2025). It had a net loss of $42.6 million. Diluted earnings per share came to −$0.53.
See the DRTS stock overview for the latest quote and news, or the DRTS chart for price history and technical indicators.
DRTS income statement FAQ
Does Alpha Tau Medical have revenue?
Alpha Tau Medical reported no revenue for fiscal year 2025, which ended on December 31, 2025.
Is Alpha Tau Medical profitable?
No. Alpha Tau Medical reported a net loss of $42.6 million in fiscal 2025.
How much does Alpha Tau Medical spend on research and development?
Alpha Tau Medical spent $30.8 million on research and development in fiscal 2025.
What are Alpha Tau Medical's earnings per share?
Alpha Tau Medical earned $-0.53 per diluted share in fiscal 2025, compared with $-0.45 a year earlier.
When will Alpha Tau Medical report its next earnings?
Alpha Tau Medical is expected to report results for the quarter ending September 30, 2026 on November 19, 2026 after the market closes.
When does Alpha Tau Medical's fiscal year end?
Alpha Tau Medical's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 9, 2026.